Thompson N. Doman

2.4k citations

24 papers · 1.5k indexed · h-index 12

Molecular Biology top 10%
Computational Theory and Mathematics top 1%
Organic Chemistry top 5%
Oncology top 10%
Materials Chemistry

Co-authors: Brian K. Shoichet Susan L. McGovern Brian Y. Feng R. Kiplin Guy Anang A. Shelat Daniel T. Connolly William C. Stallings Ravi G. Kurumbail
Topics: Cancer Immunotherapy and Biomarkers (7 papers)Computational Drug Discovery Methods (5 papers)Magnetism in coordination complexes (4 papers)
Cited by: Computational Theory and Mathematics Molecular Biology Organic Chemistry
Journals: Journal of the American Chemical Society PLoS ONE Cancer Research
Partner nations: United States United Kingdom France

In The Last Decade

Thompson N. Doman

24 papers receiving 1.4k citations

Peers

Countries citing papers authored by Thompson N. Doman

Since Specialization

Citations

This map shows the geographic impact of Thompson N. Doman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thompson N. Doman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thompson N. Doman more than expected).

Fields of papers citing papers by Thompson N. Doman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thompson N. Doman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thompson N. Doman. The network helps show where Thompson N. Doman may publish in the future.

Co-authorship network of co-authors of Thompson N. Doman

This figure shows the co-authorship network connecting the top 25 collaborators of Thompson N. Doman. A scholar is included among the top collaborators of Thompson N. Doman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thompson N. Doman. Thompson N. Doman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Treatment with a VEGFR-2 antibody results in intra-tumor immune modulation and enhances anti-tumor efficacy of PD-L1 blockade in syngeneic murine tumor models 2022 ·PLoS ONE ·Yanxia Li,Nelusha Amaladas,(unknown),Jason R. Manro,Ivan Inigo,Qi Li,Erik Rasmussen,Manisha Brahmachary,Thompson N. Doman,Gerald E. Hall,Michael Kalos,Ruslan D. Novosiadly,Óscar Puig,Bronislaw Pytowski,David Schaer	11
2	Relationship between gene expression patterns from nasopharyngeal swabs and serum biomarkers in patients hospitalized with COVID-19, following treatment with the neutralizing monoclonal antibody bamlanivimab 2022 ·Journal of Translational Medicine ·Jonathan T. Sims,(unknown),(unknown),Timothy R. Holzer,Lin Zhang,Sarah Engle,(unknown),Thompson N. Doman,(unknown),Richard E. Higgs,Nicole L. Kallewaard,Robert J. Benschop	7
3	A Phase I Study of an IDO-1 Inhibitor (LY3381916) as Monotherapy and in Combination With an Anti-PD-L1 Antibody (LY3300054) in Patients With Advanced Cancer 2021 ·Journal of Immunotherapy ·Nuria Kotecki,Perrine Vuagnat,Bert H. O’Neil,Shadia I. Jalal,Sylvie Rottey,Hans Prenen,Karim A. Benhadji,Meng Xia,Anna M. Szpurka,Abhijoy Saha,Johan Wallin,(unknown),Violeta Régnier Galvão,Sandaruwan Geeganage,Thompson N. Doman,Leena Gandhi,Xiaojian Xu,Johanna C. Bendell	29
4	Bottom-up, integrated -omics analysis identifies broadly dosage-sensitive genes in breast cancer samples from TCGA 2019 ·PLoS ONE ·Bobak Kechavarzi,Huanmei Wu,Thompson N. Doman	4
5	Abstract 4549: Pemetrexed enhances anti-tumor efficacy of PD1 pathway blockade by promoting intra tumor immune response via immunogenic tumor cell death and T cell intrinsic mechanisms 2018 ·Cancer Research ·Ruslan D. Novosiadly,David Schaer,Nelusha Amaladas,Erik Rasmussen,(unknown),(unknown),Carmine Carpenito,Yanxia Li,Shuang Luo,Andrew Capen,Catalina M. Meyer,Xiaodong Huang,Jason R. Manro,Gregory P. Donoho,Thompson N. Doman,Gerald E. Hall,Sandaruwan Geeganage,Michael Kalos	8
6	Abstract 3632: Combination of EGFR antibody with PD-1 pathway inhibitors improves anti-tumor efficacy and enhances intra-tumor immune response in preclinical mouse tumor models 2018 ·Cancer Research ·(unknown),Amélie Forest,(unknown),David Schaer,Ting Chen,Shengwu Liu,David Surguladze,Yung‐Mae Yao,Thompson N. Doman,Gerald E. Hall,Kwok‐Kin Wong,Michael Kalos,Ruslan D. Novosiadly	1
7	Abstract B108: Antitumor efficacy of EGFR antibody necitumumab and dual PI3K/mTOR inhibitor (LY3023414) in preclinical tumor models 2018 ·Molecular Cancer Therapeutics ·Maxine Melchior,Xuemei Guo,Gregory P. Donoho,Philip W. Iversen,Thompson N. Doman,Manisha Brahmachary,Xueqian Gong,Gerald E. Hall,Jason R. Manro,Yung‐Mae Yao,Sean G. Buchanan,Tod Smeal,Michael Kalos,Ruslan D. Novosiadly	1
8	Abstract 583: The CDK4/6 inhibitor abemaciclib induces synergistic immune activation and antitumor efficacy in combination with PD-L1 blockade 2017 ·Cancer Research ·Jack Dempsey,Lysiane Huber,Amélie Forest,Jennifer R. Stephens,Thompson N. Doman,Jason R. Manro,Andrew Capen,(unknown),Gregory P. Donoho,Sean G. Buchanan,Alfonso de Dios,Kyla Driscoll,Michael Kalos,Ruslan D. Novosiadly,Richard P. Beckmann,David Schaer	2
9	Timing of CSF-1/CSF-1R signaling blockade is critical to improving responses to CTLA-4 based immunotherapy 2016 ·OncoImmunology ·Rikke Holmgaard,(unknown),Billel Gasmi,David R. Jones,Marissa S. Mattar,Thompson N. Doman,Mary Y. Murphy,David Schaer,Jedd D. Wolchok,Taha Merghoub	55
10	Identification of Druggable Cancer Driver Genes Amplified across TCGA Datasets 2014 ·PLoS ONE ·Ying Chen,(unknown),Xian‐Ming Chen,Thompson N. Doman,Xueqian Gong,Youyan Zhang,(unknown),Xiwen Ma,Richard E. Higgs,Shripad V. Bhagwat,Sean G. Buchanan,Sheng-Bin Peng,Kirk A. Staschke,Vipin Yadav,Yong Yue,Hosein Kouros‐Mehr	108
11	3D QSAR Methods: Phase and Catalyst Compared 2007 ·Journal of Chemical Information and Modeling ·David A. Evans,Thompson N. Doman,David A. Thorner,Michael J. Bodkin	61
12	High-throughput assays for promiscuous inhibitors 2005 ·Nature Chemical Biology ·Brian Y. Feng,Anang A. Shelat,Thompson N. Doman,R. Kiplin Guy,Brian K. Shoichet	257
13	Identification and Prediction of Promiscuous Aggregating Inhibitors among Known Drugs 2003 ·Journal of Medicinal Chemistry ·(unknown),Susan L. McGovern,Thompson N. Doman,Brian K. Shoichet	392
14	ChemInform Abstract: Algorithm5: A Technique for Fuzzy Similarity Clustering of Chemical Inventories 1997 ·ChemInform ·Thompson N. Doman,(unknown),(unknown),(unknown),Dale Spangler	1
15	Algorithm5: A Technique for Fuzzy Similarity Clustering of Chemical Inventories 1996 ·Journal of Chemical Information and Computer Sciences ·Thompson N. Doman,(unknown),(unknown),(unknown),Dale Spangler	28
16	Molecular Mechanics Force Fields for Bent Metallocenes of the Type [M(Cp)2Cl2] 1995 ·Journal of the American Chemical Society ·Thompson N. Doman,T. Keith Hollis,B. Bosnich	45
17	Molecular mechanics force fields for linear metallocenes 1992 ·Journal of the American Chemical Society ·Thompson N. Doman,Clark R. Landis,B. Bosnich	71
18	Synthesis, crystal structure and magnetic properties of a pyrazolate-bridged binuclear copper(II) complex 1990 ·Inorganic Chemistry ·Thompson N. Doman,Donald E. Williams,(unknown),Robert M. Buchanan,H.‐R. CHANG,Robert J. Webb,David N. Hendrickson	60
19	Synthesis, crystal structure and properties of (1,3-(bis(N-methylimidazolimine)-propan-2-ol)Cu(II))·perchlorate 1989 ·Inorganica Chimica Acta ·Thompson N. Doman,John F. Richardson,(unknown),Robert M. Buchanan	18
20	Synthesis and characterization of a new binucleating schiff base macrocycle and its nickel(II) and copper(II) complexes 1988 ·Inorganica Chimica Acta ·Mark S. Mashuta,Thompson N. Doman,William M. Pierce,Robert M. Buchanan	6

About Thompson N. Doman

Thompson N. Doman is a scholar working on Oncology, Biological Psychiatry and Computational Theory and Mathematics, having authored 24 papers that have together received 1.5k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (7 papers), Computational Drug Discovery Methods (5 papers) and Magnetism in coordination complexes (4 papers). The work is most often cited by research in Computational Theory and Mathematics (501 citations), Molecular Biology (831 citations) and Organic Chemistry (345 citations). Thompson N. Doman has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Brian K. Shoichet, Susan L. McGovern, Brian Y. Feng, R. Kiplin Guy, Anang A. Shelat, Daniel T. Connolly, William C. Stallings, Ravi G. Kurumbail, Thomas P. Kasten and Bryan J. Witherbee. Their work appears in journals such as Journal of the American Chemical Society, PLoS ONE and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact